Accent Microcell Discloses IPO and Rights Issue Fund Utilisation Statement for Half-Year Ended March 31, 2026

4 min read     Updated on 13 May 2026, 11:42 AM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Accent Microcell Limited filed its SEBI Regulation 32 Statement of Deviation/Variation for both its IPO (₹7,840.00 lakhs, allotted December 13, 2023) and Rights Issue (₹3,977.127 lakhs, allotted July 17, 2025) for the half-year/year ended March 31, 2026, confirming no deviation or variation in fund utilisation for either issue. Unutilised IPO proceeds of ₹42.72 lakhs and Rights Issue proceeds of ₹1,054.86 lakhs are parked as fixed deposits with Kotak Mahindra Bank Ltd. Both statements were certified by auditors T R Chadha & Co LLP and signed by Managing Director and CFO Ghanshyam Arjanbhai Patel.

powered bylight_fuzz_icon
40198347

*this image is generated using AI for illustrative purposes only.

Accent Microcell Limited has submitted its Statement of Deviation/Variation for proceeds raised through its Initial Public Offer (IPO) and Rights Issue, in compliance with Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filings, dated May 12, 2026, cover the half-year/year ended March 31, 2026, and were addressed to the General Manager – Listing, National Stock Exchange of India Limited. Both statements confirm that there is no deviation or variation in the utilisation of funds raised from either issue.

IPO Fund Utilisation — No Deviation Reported

Accent Microcell raised ₹7,840.00 lakhs through its Public Issue, with the date of allotment recorded as December 13, 2023. As per the statement certified by auditors T R Chadha & Co LLP, the actual utilisation of IPO proceeds against the objects disclosed in the offer document is detailed below.

Parameter: Details
Name of Listed Entity: Accent Microcell Limited
Mode of Fund Raising: Public Issue
Date of Allotment: December 13, 2023
Amount Raised: ₹7,840.00 lakhs
Report Period: Half-year/year ended March 31, 2026
Deviation/Variation: No
Monitoring Agency: Not Applicable

The object-wise utilisation of IPO proceeds is presented in the table below:

Object: Amount Disclosed (₹ in lakhs) Actual Utilised (₹ in lakhs) FD Interest Credited till 31.03.2026 (₹ in lacs) Unutilised Amount (₹ in lakhs)
Plant for manufacturing CCS, SSG & CMC: 5,439.38 6,564.75 542.60 (582.76)
General Corporate Purposes: 1,790.33 1,117.22 - 673.11
Issue Related Expenses: 610.29 662.91 - (52.62)
IPO Subsidy Amount: - - 5.00 5.00
Total: 7,840.00 8,344.88 547.60 42.72

For the plant set up for manufacturing Croscarmellose Sodium (CCS), Sodium Starch Glycolate (SSG), and Carboxymethylcellulose (CMC), fixed deposit interest of ₹542.60 lacs was utilised and adjusted against the actual utilised amount. Issue-related expenses exceeded the disclosed amount by ₹52.62 lacs, which has been noted accordingly. As at March 31, 2026, a total of ₹42.72 lakhs remains unutilised from IPO proceeds. Of this, ₹2.31 lakhs is held in a Kotak Mahindra Bank Ltd. current account (A/c No. 8111793347) and ₹40.41 lakhs is placed as a fixed deposit with Kotak Mahindra Bank Ltd., Shyamal Cross Road, Ahmedabad.

Rights Issue Fund Utilisation — No Deviation Reported

Accent Microcell also raised ₹3,977.127 lakhs through a Rights Issue, with the date of allotment recorded as July 17, 2025. The auditor's certificate for this issue was issued under Ref No. 047/AHD/2026-2027, referencing the Letter of Offer to Right Issue dated May 29, 2025.

Parameter: Details
Name of Listed Entity: Accent Microcell Limited
Mode of Fund Raising: Public Issue (Right Issue)
Date of Allotment: July 17, 2025
Amount Raised: ₹3,977.127 lakhs
Report Period: Half-year/year ended March 31, 2026
Deviation/Variation: No
Monitoring Agency: Not Applicable

The object-wise utilisation of Rights Issue proceeds is presented below:

Object: Amount Disclosed (₹ in lakhs) Actual Utilised (₹ in lakhs) FD Interest Credited FY 25-26 (in lacs) Unutilised Amount (₹ in lakhs)
Plant for manufacturing Microcrystalline Cellulose: 3,232.71 2,902.20 61.37 391.87
General Corporate Purposes: 694.42 22.54 - 671.88
Issue Related Expenses: 50.00 58.90 - (8.90)
Total: 3,977.13 2,983.64 1,054.86

Fixed deposit interest of ₹61.37 lacs was utilised for the plant manufacturing object and adjusted against the actual utilised amount. Issue-related expenses exceeded the disclosed amount by ₹8.90 lacs. As at March 31, 2026, ₹1,054.86 lakhs remains unutilised from Rights Issue proceeds. Of this, ₹44.17 lakhs is held in a Kotak Mahindra Bank Ltd. current account (A/c No. 8111793591) and ₹1,010.69 lakhs is placed as a fixed deposit with Kotak Mahindra Bank Ltd., Shyamal Cross Road, Ahmedabad.

Auditor's Certification and Compliance

Both statements have been certified by T R Chadha & Co LLP, Chartered Accountants (FRN: 006711N/N500028), with Partner Brijesh Thakkar (Membership No. 135556) signing the certificates. The auditors confirmed that their examination was carried out in accordance with the Guidance Note on Reports or Certificates for Special Purposes issued by the Institute of Chartered Accountants of India (ICAI), and Standards on Auditing specified under Section 143(10) of the Companies Act, 2013. The audit committee and auditors have offered no adverse comments on either statement. The filings were signed by Ghanshyam Arjanbhai Patel, Managing Director and CFO (DIN: 05225398), on behalf of Accent Microcell Limited.

Historical Stock Returns for Accent Microcell

1 Day5 Days1 Month6 Months1 Year5 Years
+7.10%+5.37%+13.15%+52.11%+123.33%+49.84%

How will the completion of the Microcrystalline Cellulose manufacturing plant impact Accent Microcell's production capacity and revenue growth in FY 2026-27?

Given that over ₹1,097 lakhs remains unutilised across both IPO and Rights Issue proceeds, what is the company's timeline for deploying these funds and how might delays affect projected returns?

How does Accent Microcell's expansion into CCS, SSG, CMC, and Microcrystalline Cellulose position it competitively against other pharmaceutical excipient manufacturers in India?

1 Year Returns:+123.33%